IPOGrid
Focus quotidien · 24 septembre 2026
Vesicor’s Nasdaq Path Depends on Cash That Is Still Uncertain
Vesicor’s Nasdaq route rests on redemption-sensitive cash
Par Erik Aronesty · Vesicor Therapeutics, Inc.
LOS ANGELES, September 24, 2026. Vesicor Therapeutics is approaching the public market with a $70 million merger valuation, one preclinical oncology candidate and a financing plan whose usable cash remains highly sensitive to redemptions. That combination...
Lu par plus de 900 abonnés, dont plus de 300 travaillent dans des hedge funds.
IPOGrid hebdomadaire · 14 septembre 2026 – 20 septembre 2026
Holtec withdrew as Orion180 and Electra paid for IPO execution
Holtec withdrew, Orion180 cut, Electra fell after upsizing
Par Erik Aronesty · 21 septembre 2026
The fall IPO window delivered a blunt separation between access and demand in the week ended September 20. Holtec Nuclear postponed a deal that could have raised $900 million. Orion180 Insurance cut its price to $12, well below its $15 to $17 range, and still...
Lu par plus de 900 abonnés, dont plus de 300 travaillent dans des hedge funds.
Calendrier IPO
Deals dans la liste
| Société | Deal | Statut | Signal | Prix | Produit brut | Chef de file | Bourse | Dernier formulaire | Dernier filing |
|---|---|---|---|---|---|---|---|---|---|
| ipo | priced | 09-28 | $10.00 | - | EF Hutton | Nasdaq | 424B4 | 2026-09-22 | |
| ipo | priced | 09-28 | - | - | - | NYSE | EFFECT | 2026-09-22 | |
|
Oura Inc.
OURA
|
ipo | amended | Watch | $40.00 to $44.00 | $2,100,000,000 | Goldman Sachs & Co. LLC | Nasdaq Global Select Market | FWP | 2026-09-24 |
| ipo | amended | Watch | $11.00 | $42,900,000 | Kingswood Capital Partners, LLC | Nasdaq | F-1/A | 2026-09-24 | |
|
AM PM Group Ltd
AMPM
|
ipo | amended | Watch | $4.50 | $33,750,000 | Prime Number Capital LLC | Nasdaq Global Market | F-1/A | 2026-09-17 |
|
Star Integratia Ltd
ITIA
|
ipo | amended | Watch | $7.00 | $29,166,669 | EDDID SECURITIES USA INC. | Nasdaq Capital Market | F-1/A | 2026-09-17 |
| ipo | amended | Watch | $22.00 | $660,000,000 | Morgan Stanley | Nasdaq | S-1/A | 2026-09-22 | |
| ipo | amended | Active | $4.00 to $6.00 | $18,750,000 | The Benchmark Company, LLC | Nasdaq | S-1/A | 2026-09-14 | |
| ipo | amended | Active | $4.00 | $25,000,000 | ARC Group Securities LLC | Nasdaq Capital Market | F-1/A | 2026-09-04 | |
| ipo | amended | Active | $5.00 | $31,250,000 | Cathay Securities, Inc. | Nasdaq Capital Market | F-1/A | 2026-09-15 | |
| ipo | priced | 09-28 | $2.00 | $5,000,000 | self-underwritten | Nasdaq | 424B4 | 2026-09-01 | |
|
KiNRG, Inc.
BYOP
|
ipo | amended | Active | $6.00 | $18,000,000 | R.F. Lafferty & Co., Inc. | NYSE American | S-1/A | 2026-09-24 |
Voir la liste complète
Affichage de 12 noms orientés bourse sur 154 émetteurs IPO publics actifs.
Liste chaude
Noms à garder ouverts
Forgent Power Solutions, Inc.
FPS
86% revenue growth
Revenues for the nine months ended March 31, 2026 were $958.4 million as compared to $515.6 million for the nine months ended March 31, 2025.
Cover banks: Goldman Sachs & Co. LLC, Jefferies LLC, Morgan Stanley & Co. LLC · Financial texture: Revenues for the nine months ended March 31, 2026 were $958.4 million as compared to $515.6 million for the nine months ended March 31, 2025.
Accelevation Holdings Corp.
ACCV
147% revenue growth
Revenue for the year ended December 31, 2025 was $447,819 thousand
Cover banks: Morgan Stanley, J.P. Morgan, Goldman Sachs & Co. LLC +7 · Financial texture: Revenue for the year ended December 31, 2025 was $447,819 thousand · Deal terms: 30M shares · $20-$24 · $660M deal · Nasdaq ACCV
Oura Inc.
OURA
Named anchor interest
Eli Lilly and Company indicated interest in $100.0M and Dragoneer Investment Group, LLC in $300.0M
Anchor interest from Eli Lilly and Company and Dragoneer Investment Group, LLC · Financial texture: Deterministic scale normalization applied to revenuePrior1, revenuePrior2, adjustedEbitdaCurrent, adjustedEbitdaPrior1, adjustedEbitdaPrior2,... · Deal terms: 14M shares · $0 price · $2.1B deal · Nasdaq OURA
ADARx Pharmaceuticals, Inc.
ADRX
1288% revenue growth
Collaboration revenue was $2.9 million and $0.2 million for the six months ended June 30, 2026 and 2025, respectively.
Cover banks: J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, TD Securities (USA) LLC +1 · Financial texture: Collaboration revenue was $2.9 million and $0.2 million for the six months ended June 30, 2026 and 2025, respectively. · Deal terms: 22M shares · $15-$17 · $372M deal · Nasdaq Global Select Market ADRX
Columbia Financial, Inc./MD/
CLBK
Operating company numbers
Total consolidated revenues $266,046 for 2025
Cover banks: Keefe, Bruyette & Woods, Inc. · Financial texture: Total consolidated revenues $266,046 for 2025 · Deal terms: 52M shares · $10 price · $1.9B deal · Timing: We anticipate simultaneously completing the conversion, the offering and the Northfield Bancorp acquisition...
Timwood Holdings Ltd
TIWD
8.4% revenue growth
Revenue 4,287,965
Cover banks: Kingswood Capital Partners, LLC · Financial texture: Revenue 4,287,965 · Deal terms: 5.6M shares · $4-$6 · $36M deal · Nasdaq Capital Market TIWD · Timing: Approximate date of commencement of proposed sale to the public: As soon as practicable after this...